Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €526.08M | -60x | -0.78 | €3.25 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €368.19M | -1.9x | -1.49 | €5.91 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €265.94M | -1.4x | 0.29 | €2.79 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €254.61M | 42.2x | -1.71 | €25.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €170.01M | -5.3x | -0.11 | €0.57 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €163.40M | 7.4x | 0.05 | €3.35 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €155.73M | -4.4x | -0.11 | €1.89 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €141.74M | -3.8x | -0.08 | €2.99 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €126.43M | 2.7x | 0.01 | €5.79 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €126.12M | -1.3x | -0.04 | €1.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €103.91M | 10x | €20,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €90.81M | -3x | -0.12 | €0.68 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €83.59M | -4x | 0.08 | €5.66 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €78.98M | -2.9x | -0.11 | €4.39 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.7% Upside | Upgrade to Pro+ | |
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €42.93M | -11.3x | €1.24 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Institut Biophytis SAS | Paris | Healthcare | Biotechnology & Medical Research | €42.49M | -0.5x | -0 | €0.29 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €41.07M | -0.9x | 0.02 | €0.58 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €31.81M | 22.7x | €3.45 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €31.56M | -1.4x | 0.15 | €0.37 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €29.84M | -1.6x | -0.03 | €0.24 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44% Upside | Upgrade to Pro+ | |
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €18.83M | -0.4x | €1.88 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €16.74M | -1.7x | -0.09 | €1.06 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €16.11M | -10.2x | €1.63 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €14.44M | -3.1x | 0.18 | €3.86 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €12.52M | -18.7x | €11.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €11.27M | -0.5x | -0.01 | €0.21 | 8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €6.73M | -0.2x | -0.01 | €0.07 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €6.36M | €0.37 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -0.5x | -0.01 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | €3.92M | -0.2x | -0.01 | €0.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €3.60M | -1.2x | -0.02 | €0.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Integragen | Paris | Healthcare | Biotechnology & Medical Research | €3.38M | -127.5x | -1.67 | €0.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Geneuro | Paris | Healthcare | Biotechnology & Medical Research | €2.37M | -0.2x | €0.08 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Medesis Pharma | Paris | Healthcare | Biotechnology & Medical Research | €1.77M | -0.6x | -0.18 | €0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | €509.46K | -9.6x | €0.05 | 34.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Theravet | Paris | Healthcare | Biotechnology & Medical Research | €292.67K | -0.2x | -0.01 | €0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | €9K | -60.2x | €0.06 | -11% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |